Beam Therapeutics (BEAM) AI Analysis
BEAM$22.83-1.20 -4.99%
Market cap$2.36BEnterprise value$2.90BRevenue (TTM)$146.64MMarket position—
Score
68
Bullish
Value
58
Quality
45
Growth
100
Beam Therapeutics is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 68/100) in Biotechnology. Under the hood: revenue compounding ~186% annually over recent years. Street targets still imply ~189% upside.